Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Abstract Background Respiratory syncytial virus (RSV) causes a substantial burden of acute lower respiratory infection in children under 5 years, particularly in low- and middle-income countries (LMICs). Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have been shown t...

Full description

Bibliographic Details
Main Authors: Mihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, Joyce Nyiro, Patrick K. Munywoki, Stefano Tempia, Xiao Li, Marina Antillon, Joke Bilcke, Stefan Flasche, Philippe Beutels, D. James Nokes, Cheryl Cohen, Mark Jit
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Medicine
Subjects:
Respiratory syncytial virus
Cost-effectiveness analysis
Maternal vaccination
Monoclonal antibodies
Disease burden
Hospital data
Online Access:https://doi.org/10.1186/s12916-023-02806-w

Similar Items

Similar Items